New York, NY 09 May 2021: The global Isolation Beds market size is expected to reach USD 5.22 billion by 2027 according to a new study by Polaris Market Research. The report “Global Isolation Beds Market Share, Size, Trends, Industry Analysis Report, By Type (Manual, Electric, Hydraulic, and Pneumatic), By Usage (Critical, Bariatric, Medical Surgery, Pediatric, and Maternal); By End Use (General & Acute Care Hospitals, Multi-specialty Hospitals, Specialized Hospitals, and Ambulatory Surgical Centers, and Others); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.
Isolation Beds are one of the important components in any healthcare facility. In recent times, the demand for these beds has increased significantly owing to the nature of the current COVID-19 pandemic. The Isolation Beds market is suffering from both supply and demand side. From the demand side, more than 60 to 70% of the hospitals are struggling to acquire Isolation Beds, including masks, ventilators and other medical supplies. Whereas, from the supply side due to fluctuation in supply chain manufactures are not able to meet the current booming demand due to severe shortage of raw materials.
Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/isolation-beds-market/request-for-sample
With high infection rates and shortage of Isolation Beds, the government is focusing on alternate ways to increase the Isolation Beds facilities. In line with this, in April 2020, the Indian railways converted 20,000 train compartments into isolation wards. Similarly, in March 2020, Spain converted IFEMA conference hall into a hospital with 5,500 bed capacity to limit community transmission.
The factors responsible for the growth of Isolation Beds include an increase in the volume of chronic care patients, the rapid surge in COVID-19 patients, and increased preference towards home care for geriatrics. As of 23 June 2020, as per statistics published by John Hopkins University, the global cases of COVID-19 reached more than 9 million and deaths were around 471,000. The other countries more than 10,000 deaths were France (29,666), Mexico (22,584), Italy (34,657), Spain (28,324), UK (42,731), and India (13,699).
Market participants such as Invacare Corporation, Arjo Huntleigh (part of Gentige AB), Savion Industries Ltd., Joerns Healthcare, Joh. Stiegelmeyer GmbH, LINET Group, Stryker Corporation, Span-America Medical Systems, Gendron, Inc., Paramount Bed Holdings, Hill Rom Inc., Medline Industries, and Malvestio S.P.A. are some of the key players operating in the isolation beds market.
These players focus their energies on strategic mergers and acquisitions to extend their R&D capabilities which might assist them in coming up with novel technologies and thereby gain a competitive edge.
To get Incredible Discounts on this Premium Report, Click At : https://www.polarismarketresearch.com/industry-analysis/isolation-beds-market/request-for-discount-pricing
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises.
Contact Us:
Polaris Market Research
Phone: 1–646–568–9980
Email: [email protected]
New York, NY 22 Sep 2021: The global Isolation Beds market size is expected to reach USD 5.22 billion by 2027 according to a new study by Polaris Market Research.
The report “Global Isolation Beds Market Share, Size, Trends, Industry Analysis Report, By Type (Manual, Electric, Hydraulic, and Pneumatic), By Usage (Critical, Bariatric, Medical Surgery, Pediatric, and Maternal); By End Use (General & Acute Care Hospitals, Multi-specialty Hospitals, Specialized Hospitals, and Ambulatory Surgical Centers, and Others); By Regions; Segment Forecast, 2020 – 2027” gives a detailed insight into current market dynamics and provides analysis on future market growth.Isolation Beds are one of the important components in any healthcare facility.
The Isolation Beds market is suffering from both supply and demand side.
From the demand side, more than 60 to 70% of the hospitals are struggling to acquire Isolation Beds, including masks, ventilators and other medical supplies.
Whereas, from the supply side due to fluctuation in supply chain manufactures are not able to meet the current booming demand due to severe shortage of raw materials.Request For Sample Copy @ https://www.polarismarketresearch.com/industry-analysis/isolation-beds-market/request-for-sample With high infection rates and shortage of Isolation Beds, the government is focusing on alternate ways to increase the Isolation Beds facilities.
The other countries more than 10,000 deaths were France (29,666), Mexico (22,584), Italy (34,657), Spain (28,324), UK (42,731), and India (13,699).
The Spirulina Market is expected to grow at a CAGR of 10.3% from 2020-2030, according to a new research report by Next Move Strategy ConsultingSpirulina is a blue green algae with high nutrient content, usually consumed by human & animals.
It is also used as a complementary diet ingredient in aquaculture & poultry feeds owing to the presence of high protein & vitamin content.According to the report, growth in health consciousness among people and the rising demand for dietary supplements are major factors driving the spirulina market growth.
Additionally, high penetration of spirulina in industries such as cosmetics and pharmaceutical owing to the advantageous properties such as anti-aging, anti-wrinkles and othersare bringing changes in market tends.However, low stability & poor sustainability of spirulina derived colours is expected to restrict the market growth.Moreover, growth in research & development activities followed by untapped market opportunities in developing economies are anticipated to provide numerous opportunities to the market players in the coming few years.On the basis of type, spirulina market share is segmented into Arthrospira Platensis and Arthrospira Maxima.
Arthrospira Maxima dominates the global Spirulina market and will be the dominant throughout the forecasted period.On the basis of application, the Spirulina market is categorised into Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others.Food & Beverages segment is likely to develop significantly over the period of time owing to fast growing food & beverage industry.On the basis of drug formulation, the spirulina market is bifurcated into Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent.
Powder segment is expected to account for the major market share & dominate the market growth over the forecast period.North America dominates the spirulina market in terms of market size over the forecast period, owing to rising health consciousness among people.
Hansen Holding A/S, Algenol Biofuels Inc., Dongtai City Spirulina Bio-engineering Co., Ltd., Prolgae, Parry Neutraceuticals, Sensient Technologies Corporation, DDW Inc., Algatec and Naturex S.A.Browse key industry insights from the report, “Spirulina Market Size By Type (ArthrospiraPlatensis and Arthrospira Maxima) By Application (Nutraceuticals, Food & Beverages, Cosmetics, Animal Feed, and Others), By Drug Formulation (Powder, Tablet & Capsule, Liquid, and Granule & Gelling Agent)Regional Outlook (U.S., Canada, Germany, UK, France, Spain, Italy, Russia, China, India, Japan, Australia, Indonesia, Malaysia, South Korea, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Kuwait), Growth Potential, Price Trends, Competitive Market Share & Forecast, 2020–2030” in detail along with the table of contents:Key Insights from the Spirulina Market Report:Asia Pacific is the fastest growing region in Spirulina market owing to the rising demand of spirulina from various industries such as cosmetics, food , healthcare and others and government initiatives to promote local spirulina production.The Food & Beverages segment dominates the market in terms of application and is expected to grow at a significant CAGR to maintain the lead till 2030.Some of the major players in the market are DIC Corporation, Cyanotech Corporation, Chr.
Non-Small Cell Lung Cancer Market is Expected to Increase With a CAGR of 10.7% for the Study Period of 2017-2030: DelveInsight (Albany, US) DelveInsight has introduced a new Market Insights, Epidemiology, and Market Forecast Report on "Non-Small Cell Lung Cancer Market Insights, Epidemiology, and Market Forecast-2030" to its portfolio.Key Highlights from report are:As per the DelveInsight analysis, the total incident cases of NSCLC in the 7MM were observed to be 484,726 cases in the year 2017.
These cases are expected to grow with a significant CAGR in the study period 2017–2030.There are different types of treatment available for NSCLC; however, mainly 10 types of standard treatment are used, which include Surgery, Radiation therapy, Chemotherapy, Targeted therapy, Immunotherapy, Laser therapy, Photodynamic therapy (PDT), Cryosurgery, Electrocautery, and Watchful waiting.The market size of NSCLC in the 7MM is expected to increase during study period.
According to the estimates, the highest contribution in the market size of NSCLC is from the United States followed by Japan, Germany, and the UK.One of the most exciting developments in lung cancer medicine is the introduction of targeted treatments.Request for free sample pages to know more on Non-Small Cell Lung Cancer Market Forecast NSCLC is the most common type of lung cancer accounted for approximately 85% of all lung cancers.
The disease epidemiology included in the report provides historical as well as forecasted Non-Small Cell Lung Cancer epidemiology, which is segmented as Total Incident cases of NSCLC patients, Total Incident cases of NSCLC patients by Histology, Total Diagnosed cases of NSCLC patients by Stages, Total NSCLC cases of patients by Genetic mutation/Biomarkers, and Total Treated Cases of NSCLC patients by Line of Therapies scenario of NSCLC in the 7MM.The total NSCLC incident cases in the 7MM were observed to be 484,726 cases in 2017.Click here to know more on Non-Small Cell Lung Cancer pipelineNSCLC report encloses the detailed analysis of Non-Small Cell Lung Cancer marketed drugs and late stage (Phase-III and Phase-II) pipeline drugs.
The therapies that are approved for the NSCLC treatment are Rozlytrek (Entrectinib), Imfinzi (Durvalumab), Opdivo (Nivolumab), Tecentriq (Atezolizumab), Keytruda (Pembrolizumab), Tafinlar (Dabrafenib) in combination with Mekinist (Trametinib), Tagrisso (osimertinib), Lorbrena/Lorviqua (Lorlatinib), Vizimpro (Dacomitinib), Alunbrig (Brigatinib), Alecensa (Alectinib), Vitrakvi (Larotrectinib), Portrazza (Necitumumab) along with many more.Drugs covered in the report are:-There are several key players robustly involved in developing potential products such asNazartinib (EGF816)Capmatinib (INC280)Tepmetko (tepotinib)MerestinibJNJ-61186372 (JNJ-6372)Vemurafenib Plus CobimetinibX-396 (Ensartinib)Tedopi (OSE2101)Selpercatinib (LY3527723/ LOXO-292)SAR408701Braftovi (encorafinib) + Mektovi (binimetinib)PADCEV (enfortumab vedotin/ASG-22ME)Pralsetinib (BLU-667)TAK-788: Canakinumab (ACZ885)Avelumab (Bavencio)Veliparib (ABT-888): Sitravatinib (MGCD516)TesevatinibRomiplostim: CabozantinibSym015AMG 510INCMGA00012 (MGA012)Libtayo (Cemiplimab)BavituximabM7824 (Bintrafusp alfa)And many others Key Players covered in the report are:-Novartis PharmaceuticalsMerck KGaAEli Lilly and CompanyJanssen Research & DevelopmentHoffmann-La RocheXcoveryBeyondSpring PharmaceuticalsOSE ImmunotherapeuticsSanofiPfizerAstellas PharmaSeattle GeneticsBlueprint Medicines CorporationTakedaAbbVieKadmon CorporationAmgenSymphogenRegeneron PharmaceuticalsPeregrine PharmaceuticalsAvid BioservicesGlaxoSmithKlineAnd many othersThe report includes provides in depth analysis historical and forecasted Market Share (%) Distribution of NSCLC, Market Share (%) Distribution of NSCLC by Mutations/Biomarkers, Total Market Size of PD-L1 NSCLC, Total Market Size of BRAF NSCLC, Total Market Size of c-Met, Total Market Size of EGFR, Total Market Size of ALK as well.The reasons for buying this report:The report proffers an overview of pathophysiology, various diagnostic approaches and NSCLC treatment algorithm, including detailed chapters for marketed products and emerging therapies.Historical and forecasted Non-Small Cell Lung Cancer epidemiology in 7MM covering the United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan from 2017-2030.Detailed historical and forecasted NSCLC market covering the United States, EU5 and Japan from 2017-2030.
Pipeline analysis across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with comprehensive clinical profiles, key cross-competition, launch date along with product development activities.
